Multiplexed Diagnostics Market by Technology (Low Density Multiplexed Assays, Microplate Assays, Quantitative PCR, Medium Density Multiplexed Assays, Antibody Arrays, Bead-Based Arrays, Mass Spectrometry, Reverse Arrays, High Density Multiplexed Assays, Bacterial Artificial Chromosome Arrays, Protein Arrays, Very High Density Multiplexed Assays, Oligonucleotide Arrays, Phage Display, Next Generation Sequencing Assays), and Applications (Allergies, Autoimmune Diseases, Cardiac Disorders, Infectious Disease Diagnosis, Oncology) and Forecast 2017-2021

Multiplexed Diagnostics Market by Technology (Low Density Multiplexed Assays, Microplate Assays, Quantitative PCR, Medium Density Multiplexed Assays, Antibody Arrays, Bead-Based Arrays, Mass Spectrometry, Reverse Arrays, High Density Multiplexed Assays, Bacterial Artificial Chromosome Arrays, Protein Arrays, Very High Density Multiplexed Assays, Oligonucleotide Arrays, Phage Display, Next Generation Sequencing Assays), and Applications (Allergies, Autoimmune Diseases, Cardiac Disorders, Infectious Disease Diagnosis, Oncology) and Forecast 2017-2021

Multiplexed diagnostics involves analyzing large number of target analytes present in biochemical substances, cells of an organism, or an organic sample for disease diagnosis, quantitatively as well as qualitatively. Multiplexed diagnostics assays are preferred over single plex assays considering its low cost, high throughout nature and less turnaround time. Multiplexed assays are also used in drug discovery and phases of clinical development in pharmaceutical industries, scientific research and genomic screening. Automation, technological advancement, widespread availability, and higher prevalence of cancer and infectious diseases has driven the growth of global multiplexed diagnostics market.

The global multiplexed diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global multiplexed diagnostics market segmentation is based on technology (low density multiplexed assays, microplate assays, quantitative PCR, medium density multiplexed assays, antibody arrays, bead-based arrays, mass spectrometry, reverse arrays, high density multiplexed assays, bacterial artificial chromosome arrays, protein arrays, very high density multiplexed assays, oligonucleotide arrays, phage display, next generation sequencing assays), and applications (allergies, autoimmune diseases, cardiac disorders, infectious disease diagnosis, oncology).

The global multiplexed diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global multiplexed diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global multiplexed diagnostics market and included in this report are Affymetrix, Agilent Technologies, Gen-Probe, Inc., bioMerieux, Luminex Corporation, Illumina, Inc. and Life Technologies (Thermo Fisher Scientific).

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Multiplexed Diagnostics Market

1. Technology
1.1. Low Density Multiplexed Assays (plex ≤ 5)
1.1.1. Microplate Assays
1.1.2. Quantitative PCR
1.2. Medium Density Multiplexed Assays (plex < 500) 1.2.1. Antibody Arrays 1.2.2. Bead-based Arrays 1.2.3. Mass Spectrometry 1.2.4. Reverse Arrays 1.3. High Density Multiplexed Assays (500 ≤ plex ≤ 10,000) 1.3.1. Bacterial Artificial Chromosome Arrays 1.3.2. Protein Arrays 1.4. Very High Density Multiplexed Assays (> 10,000-plex)
1.4.1. Oligonucleotide Arrays
1.4.2. Phage Display
1.5. Next Generation Sequencing Assays

2. Application
2.1. Allergies
2.2. Autoimmune diseases
2.3. Cardiac Disorders
2.4. Infectious Disease Diagnosis
2.5. Oncology
2.6. Others

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Affymetrix, Inc.
4.2. Agilent Technologies, Inc.
4.3. bioMerieux, Inc.
4.4. Bio-Rad Laboratories, Inc.
4.5. Illumina, Inc.
4.6. F. Hoffman-La Roche, Ltd.
4.7. Gen-Probe, Inc.
4.8. Life Technologies Corporation
4.9. Luminex Corporation
4.10. Seegene, Inc.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*